Cargando…
A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
The prognostic role of serum LDH, CA19-9, CRP and ALB in PDAC patients are controversial. In contrast to single factor, there is much less information about the prognostic value of the combination of the four factors in locally advanced and metastatic PDAC patients. It's essential to set up a s...
Autores principales: | Wang, Yi, Xiao, Xiuying, Wang, Tianyi, Li, Lin, Zhu, Yue, Xu, Haiyan, Chu, Yuening, Jiao, Feng, Cui, Jiujie, Wang, Liwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907678/ https://www.ncbi.nlm.nih.gov/pubmed/29675111 http://dx.doi.org/10.7150/jca.23984 |
Ejemplares similares
-
A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma
por: Cui, Jiujie, et al.
Publicado: (2021) -
Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma
por: Han, Ting, et al.
Publicado: (2020) -
Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression
por: Quan, Ming, et al.
Publicado: (2020) -
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
por: Wang, Yu, et al.
Publicado: (2021) -
A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis
por: Zhuo, Meng, et al.
Publicado: (2018)